Suppr超能文献

血管紧张素酶将局部产生的血管紧张素 II 限制在血管壁内。

Angiotensinases restrict locally generated angiotensin II to the blood vessel wall.

作者信息

Hilgers K F, Bingener E, Stumpf C, Müller D N, Schmieder R E, Veelken R

机构信息

Department of Medicine IV, University of Erlangen, Germany.

出版信息

Hypertension. 1998 Jan;31(1 Pt 2):368-72. doi: 10.1161/01.hyp.31.1.368.

Abstract

We tested the hypothesis that angiotensinases limit the spillover of locally formed angiotensin II into the circulation. The release of angiotensin peptides from isolated rat hindquarters perfused with an artificial medium was measured by high-performance liquid chromatography and radioimmunoassay. The spontaneous release of angiotensins was increased by the angiotensinase inhibitors phenanthroline (850+/-195 versus 95+/-33 fmol of angiotensin I per 30 minutes in controls, P<.05, n=5 each) and amastatin (P<.05, n=5 each). Infusion of renin induced sustained local angiotensin I formation, which was also increased by phenanthroline. Stimulation of local angiotensin formation by renin infusion was compared with infusion of exogenous angiotensin II. Renin caused similar increases of perfusion pressure (11.1+/-2.2 versus 7.6+/-1.9 mm Hg after angiotensin II, P>.05) despite lower angiotensin II levels in the venous effluent than during infusion of exogenous angiotensin II (65+/-2 versus 482+/-33 fmol/mL, P<.05, n=7 each). Thus, renin must have caused higher angiotensin II tissue levels than indicated by the measurements in the venous effluent. The pressor response to renin was abolished by the type 1 angiotensin II receptor antagonist losartan. We conclude that the major part of locally generated angiotensins is not released into the circulation but degraded by angiotensinases within the tissue compartment.

摘要

我们验证了血管紧张素酶限制局部生成的血管紧张素II进入循环的假说。通过高效液相色谱法和放射免疫分析法测定了用人工培养基灌注的大鼠离体后肢中血管紧张素肽的释放。血管紧张素酶抑制剂菲咯啉(对照组每30分钟血管紧张素I为95±33 fmol,处理组为850±195 fmol,P<0.05,每组n=5)和氨肽酶抑制剂(每组n=5,P<0.05)可增加血管紧张素的自发释放。输注肾素可诱导局部血管紧张素I持续生成,菲咯啉也可使其增加。将肾素输注刺激局部血管紧张素生成与外源性血管紧张素II输注进行比较。尽管肾素输注后静脉流出液中的血管紧张素II水平低于外源性血管紧张素II输注时(分别为65±2与482±33 fmol/mL,P<0.05,每组n=7),但肾素引起的灌注压升高相似(分别为11.1±2.2与7.6±1.9 mmHg,P>0.05)。因此,肾素必定导致组织中的血管紧张素II水平高于静脉流出液测量值所示。1型血管紧张素II受体拮抗剂氯沙坦消除了对肾素的升压反应。我们得出结论,局部生成的血管紧张素的主要部分不会释放到循环中,而是在组织隔室内被血管紧张素酶降解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验